EFM
ORGO icon

E Fund Management’s Organogenesis Holdings ORGO Stock Holding History

E Fund Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-25,808
Closed -$126K – 340
2022
Q2 		$126K Buy
25,808
+14,028
+119% +$86.3K 0.01% 316
2022
Q1 		$90K Sell
11,780
-769
-6% -$5.95K ﹤0.01% 318
2021
Q4 		$116K Buy
+12,549
New +$133K ﹤0.01% 284

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

E Fund Management's ORGO Position: Q3 2022 in Review

E Fund Management sold out of Organogenesis Holdings (ORGO) in Q3 2022, closing a stake of 25,808 shares — an estimated $126K sold.

E Fund Management first reported a position in ORGO in Q4 2021 and held it in 3 quarters. The position peaked at $126K in Q2 2022. 154 funds tracked by Wall St. Rank hold ORGO as of Q3 2022.

  • E Fund Management reported no remaining Organogenesis Holdings position as of Q3 2022 after selling out during the quarter.
  • E Fund Management sold 25,808 Organogenesis Holdings shares in Q3 2022, an estimated $126K.
  • E Fund Management first reported a position in Organogenesis Holdings in Q4 2021 and held it in 3 quarters.
  • E Fund Management's Organogenesis Holdings position peaked at $126K in Q2 2022.
  • 154 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2022.

Based on E Fund Management's 13F filing for Q3 2022, filed 14 Nov 2022.